麥哲倫油氣 MMP 深 滬
等待開盤 03-26 09:30:00 美东时间
69.00
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 69.00
- 總市值 139.38亿
- 52周最高 69.90
- 市盈率 靜 16.58
- 換手率 0.00%
- 52周最低 41.0836
- 委 比 0.00%
- 總股本 2.02亿
- 歷史最高 69.90
- 量 比 0
- 振 幅 0.00%
- 歷史最低 7.2676
- 每 手 1
- 風險率 0.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Gain Therapeutics to Present at the 38th Annual ROTH Conference
Gain Therapeutics, Inc. announced that CEO Gene Mack will participate in a fireside chat and one-on-one meetings at the 38th Annual ROTH Conference on March 22-24, 2026, in Dana Point, CA. The fireside chat will take place on March 23, 2026, at 11:30 a.m. PT. Gain is a clinical-stage biotech company focused on next-generation allosteric therapies, with its lead candidate GT-02287 in a Phase 1b trial for Parkinson’s disease and potential for other...
03-19 20:57
Magellan Finalises A$165 Million On-Market Share Buy-Back
An announcement from Magellan Financial Group Ltd ( ($AU:MFG) ) is now availabl...
03-19 05:58
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Gain Therapeutics announced presentations at the AD/PD 2026 conference on GT-02287, a potential disease-modifying therapy for Parkinson’s disease. Initial Phase 1b results will be shared, highlighting CNS target engagement and early clinical improvements. The company expects to initiate a Phase 2 trial in 3Q26 after submitting additional preclinical data to the FDA. GT-02287 aims to restore GCase enzyme function, addressing a key pathological dri...
03-12 11:00
Magellan Aerospace declares CAD 0.05 dividend
Magellan Aerospace (MALJF) declares CAD 0.05/share quarterly dividend, in line with previous. Payable March 31; for shareholders of record March 17; ex-div March 17. See MALJF Dividend Scorecard, Yiel...
03-09 13:54
Magellan Calls April Extraordinary Meeting, Expands Remote Shareholder Access
The latest announcement is out from Magellan Financial Group Ltd ( ($AU:MFG) )....
03-06 06:57
BREAKINGVIEWS-Boutique bank deal champions long-term greed
BREAKINGVIEWS-Boutique bank deal champions long-term greed The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Antony Currie MELBOURNE, March 2 (Reuters Breakingviews) - A few Tim Tams now or a boxful later? Barrenjoey Capital Partners, the fast-growing newcomer i
03-02 13:27
Magellan Financial to acquire Barrenjoey in $1.1B deal
Australia’s Magellan Financial Group (MGLLF) has agreed to acquire Barrenjoey Capital Partners in a transaction valuing the boutique firm at about A$1.62 billion ($1.1 billion). Under the agreement, M...
03-02 05:55
Magellan Financial Group Flags Proposed Issue of New Securities
Magellan Financial Group Ltd ( ($AU:MFG) ) has shared an announcement. Magellan...
03-02 05:27
Magellanic Cloud announces end of independent director’s tenure in 2026
Magellanic Cloud Ltd. ( ($IN:MCLOUD) ) has provided an announcement. Magellanic...
02-25 18:25
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Gain Therapeutics的管理层将参加Oppenheimer的第36届年度医疗保健生命科学会议，并于2月25日下午1:20 ET参与炉边聊天。会议详情和回放可通过公司网站获取。投资者可联系Oppenheimer代表安排一对一会议。该公司专注于开发下一代变构疗法，其主要候选药物GT-02287正在针对帕金森病及其他神经退行性疾病进行临床试验。Gain利用其Magellan平台加速药物发现，致力于解决难治性疾病。
02-19 12:00
